Morphological, biochemical and molecular biology approaches for the diagnosis of lysosomal storage diseases

Journal of Veterinary Diagnostic Investigation

Volumn 12, Issue 6, 2000, Pages 483-496

  Warren, Christopher D ^a   Alroy, Joseph ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; DOMESTIC ANIMAL; HUMAN; LYSOSOME STORAGE DISEASE; METHODOLOGY; MOLECULAR BIOLOGY; PATHOLOGY; REVIEW;

ANIMALS; ANIMALS, DOMESTIC; HUMANS; LYSOSOMAL STORAGE DISEASES; MOLECULAR BIOLOGY;

EID: 0034327951     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063870001200601     Document Type: Article

References (110)

1. Abeling NGGM, Rusch H, van Gennip AH: 1996, Improved selectivity of urinary oligosaccharide screening using two one-dimensional TLC systems. J Inher Metab Dis 19:260-262.
2. Alroy J, De Gasperi R, Warren CD: 1991, Application of lectin histochemistry and carbohydrate analysis to the characterization of lysosomal diseases. Carbohydr Res 213:229-250.
3. Alroy J, Freden GO, Goyal V, et al.: 1989, Morphology of leukocytes from cats affected with α-mannosidosis and mucopolysaccharidosis VI (MPS VI). Vet Pathol 26:294-302.
4. Alroy J, Haskins M, Birk DE. 1999, Altered corneal matrix organization is associated with mucopolysaccharidosis I, III and VI. Exp Eye Res 68:523-530.
5. Alroy J, Lee RE: In press, Lysosomal storage diseases. In: Orthopaedic pathology, eds. Rosenberg AE, Schiller A, Klein M. WB Saunders, Philadelphia, PA.
6. M1-gangliosidosis: a clinical, morphologic, histochemical, and biochemical comparison of two different models. Am J Pathol 140:675-689.
7. Alroy J, Orgad U, Ucci AA, Gravis VE: 1985, Swainsonine toxicosis mimics lectin histochemistry of mannosidosis. Vet Pathol 22:311-316.
8. Alroy J, Orgad U, Ucci AA, Pereira MEA: 1984, Identification of glycoprotein storage diseases by lectins. A new diagnostic method. J Histochem Cytochem 32:1280-1284.
9. Alroy J, Schunk KL, Raghavan SS, et al.: 1988, Alpha-mannosidase deficiency in Persian cats: a model of human alpha-mannosidosis. In: Lipid storage disorders: biological and medical aspects, eds. Salvayre R, Douste-Blaze L, Gatt S, pp. 649-659. Plenum, New York, NY.
10. Alroy J, Ucci AA, Goyal V, Woods W: 1986, Lectin histochemistry of glycolipid storage diseases on frozen and paraffin-embedded tissue sections. J Histochem Cytochem 34:501-505.
11. Alroy J, Warren CD, Raghavan SS, et al.: 1987, Biochemical, ultrastructural and histochemical studies of cat placentae deficient in activity of lysosomal α-mannosidase. Placenta 8:545-553.
12. Bargal R, Bach G: 1997, Mucolipidosis type IV: abnormal transport of lipid to lysosomes. J Inher Metab Dis 20:625-632.
13. Baron R, Neff L, Louvard D, Courtoy PJ: 1985, Cell-mediated extracellular acidification and bone resorption: evidence for low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol 101:2210-2222.
14. Barone R, Carchon H, Jansen E, et al: 1998, Lysosomal enzyme activities in serum and leukocytes from patients with carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase deficiency). J Inher Metab Dis 21:167-172.
15. Berg T, Tollersrud OK, Walkley SU, et al.: 1997, Purification of feline lysosomal α-mannosidase, determination of its cDNA sequence and identification of a mutation causing α-mannosidosis in Persian cats. Biochem J 328:863-870.
16. Bermudez AJ, Johnson GC, Vanier MT, et al.: 1995, Gangliosidosis in emu (Dromaius novaehollandiae). Avian Dis 39: 292-303.
17. Berry HK: 1987, Screening for mucopolysaccharide disorders with the Berry spot test. Clin Biochem 20:365-371.
18. Beutler E, Gelbart T: 1998, Hematologically important mutations: Gaucher disease. Blood Cells Mol Dis 15:2-8.
19. Beutler E, Grabowski GA: 1995, Gaucher disease. In: The metabolic and molecular basis of inherited diseases, eds. Scriver CR, Beaudet AL, Sly WS, Valle D, 7th ed., vol. 2, pp. 2641-2670. McGraw Hill, New York, NY.
20. Bunge S, Steglich C, Lorenz P, et al.: 1994, Prenatal diagnosis and carrier detection in mucopolysaccharidosis type II by mutation analysis. A 47, XY male heterozygous for a missense point mutation. Prenatal Diag 14:777-780.
21. Byers S, Rozaklis T, Bramfield LK, et al.: 1998, Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS. Mol Genet Metabol 65:282-290.
22. Castagnaro M, Alroy J, Ucci AA, Glew RH: 1987, Lectin histochemistry and ultrastructure of feline kidneys from six different storage diseases. Virchows Arch B Cell Pathol 54:16-26.
23. Cavanagh KT, Leipprandt JR, Jones MZ, Friderici K: 1995, Molecular defect of caprine N-acetylglucosamine-6-sulphatase deficiency. A single base substitution creates a stop codon in the 5′-region of the coding sequence. J Inher Metab Dis 18: 96.
24. Chen C-S, Bach G, Pagano RE: 1998, Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. Proc Natl Acad Sci USA 95:6373-6378.
25. M2 gangliosidosis. Am J Pathol 90:723-734.
26. Cummings JF, Wood PA, de Lahunta A, et al: 1988, The clinical and pathologic heterogeneity of feline alpha-mannosidosis. J Vet Intern Med 2:163-170.
27. M2-gangliosidosis in a Japanese Spaniel. Acta Neuropathol 67:247-253.
28. Dahl DL, Warren CD, Rathke EJS, Jones MZ: 1986, β-mannosidosis: prenatal detection of caprine allantoic fluid oligosaccharides with thin layer, gel permeation and high performance liquid chromatography. J Inher Metab Dis 9:93-98.
29. d'Azzo A, Andria G, Strisciuglio P, Galjaard H: 1995, Galactosialidosis. In: The metabolic and molecular basis of inherited diseases, eds. Scriver CR, Beaudet AL, Sly WS, Valle D, 7th ed., vol. 2, pp. 2825-2837. McGraw Hill, New York, NY.
30. Dorling PR: 1984, Lysosomal storage diseases in animals. In: Lysosomes in biology and pathology, eds. Dingle JT, Dean RT, Sly W, pp. 347-379. Elsevier, Amsterdam, The Netherlands.
31. M2 gangliosidosis variant with HEXA splicing defect: quantitation of HEXA mRNAs in normal and mutant fibroblasts. Eur J Hum Genet 5:129-136.
32. Fujimura H, Ogura A, Asano T, et al.: 1996, Lysosomal glycolipid storage in renal tubular epithelium in mastomys (Praomys coucha). Histol Histopathol 11:171-174.
33. Fyfe JC, Kurzhals RL, Giger U, et al.: 1996, Missense mutation causes beta-glucuronidase deficiency in feline MPS VII. Am J Hum Genet 59:A197.
34. Gahl WA, Schneider JA, Aula PP: 1995, Lysosomal transport disorders: cystinosis and sialic acid storage disorders. In: The metabolic and molecular basis of inherited diseases, eds. Scriver CR, Beaudet AL, Sly WS, Valle D, 7th ed., vol. 2, pp. 3763-3797. McGraw Hill, New York, NY.
35. Gelb BD, Shi G-P, Chapman HA, Desnick RJ: 1996, Pycnodysostosis, a lysosomal storage disease caused by cathepsin K deficiency. Science 273:1236-1238.
36. Giger U, Shivaprasad H, Wang P, et al.: 1997, Mucopolysaccharidosis type IIIB (Sanfilippo B syndrome) in emus. Vet Pathol 34:473A.
37. Giudici TA, Sunico H, Blaskovics M: 1996, Diagnostic screening for mucopolysaccharidoses I-VII by fluorophore-labelled carbohydrate PAGE. J Inher Metab Dis 19:263-266.
38. M2 gangliosidoses. In: The metabolic and molecular basis of inherited diseases, eds. Scriver CR, Beaudet AL, Sly WS, Valle D, pp. 2839-2882, 7th ed., vol. 2. McGraw Hill, New York, NY.
39. Hanichen T, Brem G, Spiess C, Hermanns W: 1995, Canine lipid storage disease. Eur J Vet Pathol 1:37-44.
40. Hannun YA, Bell RM: 1987, Lysosphingolipids inhibit protein kinase C: implications for sphingolipidoses. Science 235:670-674.
41. Hansen HG, Graucob E: 1985, Hematologic cytology of storage diseases. Springer-Verlag, Berlin, Germany.
42. Harper PAW, Walker KH, Healy PJ, et al: 1988, Neurovisceral ceroid-lipofuscinosis in blind Devon cattle. Acta Neuropathol 75:632-636.
43. Haskins M, Giger U: 1997, Lysosomal storage diseases. In: Clinical biochemistry of domestic animals, eds. Kaneko H, Harvey JW, Bruss ML, 5th ed., pp. 741-760. Academic New York, NY.
44. Herschkowitz N, Schulte J: 1984, Lipidoses: from defect and dysfunction. Neuropediatrics 1(Suppl):110-111.
45. Holleran WM, Ginns EI, Menon G, et al.: 1994, Epidermal consequence of β-glucocerebrosidase deficiency: permeability barrier alterations and basis for skin lesions in type 2 Gaucher disease. J Clin Invest 93:1756-1764.
46. M2-gangliosidosis in a Japanese Spaniel. J Neurochem 480:860-864.
47. Jarplid B, Haltia M: 1993, An animal model of the infantile type of neuronal ceroid-lipofuscinosis. J Inher Metab Dis 16: 274-277.
48. Jolly RD, Palmer DN: 1995, The neuronal ceroid-lipofuscinoses (Batten disease): comparative aspects. Neuropathol Appl Neurobiol 21:50-60.
49. Jolly RD, Walkley SU: 1997, Lysosomal storage diseases of animals: an essay in comparative pathology. Vet Pathol 34: 527-548.
50. Jones MZ, Alroy J, Boyer PJ, et al.: 1998, Caprine mucopolysaccharidosis-IIID: clinical, biochemical, morphological and immunohistochemical characteristics. J Neuropathol Exp Neurol 57:148-157.
51. Judge MR, Atherton DJ, Salvayre R, et al.: 1994, Neutral lipid storage disease. Case report and lipid studies. Br J Dermatol 130:507-510.
52. M1 gangliosidosis. Pediatr Neurol 8:255-261.
53. Kim D-Y, Cho D-Y, Taylor HW: 1996, Lysosomal storage disease in an emu (Dromaius novaehollandiae). Vet Pathol 33: 365-366.
54. King NW, Alroy J: 1997, Lysosomal storage diseases. In: Veterinary pathology, eds. Jones TC, Hunt RD, King NW, pp. 30-50, 6th ed., Williams and Wilkins, Media, PA.
55. Knowles K, Alroy J, Castagnaro M, et al.: 1993, Adult-onset lysosomal storage disease in a Schipperke dog: clinical, morphological and biochemical studies. Acta Neuropathol 86:306-312.
56. Kolodny EH, Fluharty AL: 1995, Metachromatic leukodystrophy and multiple sulfatase deficiency: sulfatide lipidoses. In: The metabolic and molecular basis of inherited diseases, eds. Scriver CR, Beaudet AL, Sly WS, Valle D, 7th ed., vol. 2, pp. 2693-2740. McGraw Hill, New York, NY.
57. Kornfeld S, Sly WS: 1995, I-cell disease and pseudo-Hurler polydystrophy: disorders of lysosomal enzyme phosphorylation and localization. In: The metabolic and molecular basis of inherited diseases, eds. Scriver CR, Beaudet AL, Sly WS, Valle D, 7th ed., vol. 2, pp. 2495-2508. McGraw Hill, New York, NY.
58. Kunieda T, Simonaro CM, Yoshida M, et al.: 1995, Mucopolysaccharidosis type VI in rats: isolation of cDNA encoding arylsulfatase B, chromosomal localization of the gene, and identification of the mutation. Genomics 29:582-587.
59. Kunita R, Nakabayashi O, Wu J-Y, et al.: 1998, Molecular cloning of acid α-glucosidase cDNA of Japanese quail (Coturnix cotrnix japonica) and the lack of its mRNA in acid maltase deficient quails. Biochem Biophys Acta 1362:269-278.
60. Leinekugel P, Michel S, Conzelmann E, Sandhoff K: 1992, Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet 88:513-523.
61. Leipprandt JR, Chen H, Horvath JE, et al.: 1999, Identification of a bovine β-mannosidosis mutation and detection of two β-mannosidase pseudogenes. Mamm Genome 10:1137-1141.
62. Leipprandt JR, Friderici K, Sprecher DJ, Jones MZ: 1995, Prenatal testing for caprine N-acetylglucosamine-6-sulphatase deficiency and sex identification. J Inher Metab Dis 18:647-648.
63. Leipprandt JR, Kraemer SA, Haithcock BE, et al.: 1996, Caprine β-mannosidase: sequencing and characterization of the cDNA and identification of the molecular defect of caprine β-mannosidosis. Genomics 37:51-56.
64. Lhotka JF: 1953, Some histochemical observations on periodic acid-amino-acid mechanisms. Nature 171:1123-1124.
65. Lovell KL: 1990, Caprine β-mannosidosis: development of glial and myelin abnormalities in optic nerve and corpus callosum. Glia 3:26-32.
66. Lovell KL, Sprecher DJ, Ames NK, Jones MZ: 1995, Development and efficacy of ultrasound-guided fetal fluid aspiration techniques for prenatal diagnosis of caprine-mannosidosis. Theriogenology 44:517-527.
67. Luzi P, Rafi MA, Victoria T, et al.: 1997, Characterization of the Rhesus monkey galactocerebrosidase (GALC) cDNA and gene identification of mutation causing globoid cell leukodystrophy (Krabbe disease) in this primate. Genomics 42:319-324.
68. Maatta A, Jarvelainen HT, Nelimarkka LO, Penttinen RP: 1994, Fibroblast expression of collagen and proteoglycans is altered in aspartylglucosaminuria, a lysosomal storage disease. Biochim Biophys Acta 1225:264-270.
69. Menon KP, Tieu PT, Neufeld EF: 1992, Architecture of the canine IDUA gene and mutation underlying canine mucopolysaccharidosis I. Genomics 14:763-768.
70. M2-gangliosidosis (Sandhoff disease). Am J Pathol 124: 1109-1118.
71. M1-gangliosidosis. J Inher Metab Dis 21:430-431.
72. Musumeci S, D'Agata A, Romano C, et al.: 1988, Ichthyosis and neutral lipid storage disease. Am J Med Genet 29:377-382.
73. Nadel HL: 1973, Acid phosphatase deficiency. In: Lysosomes and storage diseases, eds. Hers HG, van Hoof F, pp. 475-484. Academic New York, NY.
74. Nanto-Salonen K, Larjava H, Saamanen A-M, Heino J, et al.: 1987. Abnormal dermal proteoglycan in aspartyglucosaminuria: a possible mechanism for ultrastructural changes of collagen fibrils in a glycoprotein storage disorder. Connect Tissue Res 16:367-376.
75. Nanto-Salonen K, Pelliniemi LJ, Auito S, et al.: 1984, Abnormal collagen fibrils in aspartylglucosaminuria. Altered dermal ultrastructure in a glycoprotein storage disorder. Lab Invest 51: 464-468.
76. Natowicz MR, Short MP, Wang Y, et al.: 1996, Clinical and biochemical manifestations of hyaluronidase deficiency. N Engl J Med 335:1029-1033.
77. Neufeld EF: 1989, Natural history and inherited disorders of lysosomal enzyme, β-hexosaminidase. J Biol Chem 264: 10927-10930.
78. Neufeld EF: 1991, Lysosomal storage diseases. Annu Rev Biochem 60:257-280.
79. M2-gangliosidosis (Sandhoff's disease) in Korat cats. J Clin Invest 76:482-490.
80. Obeid LM, Linardic CM, Karolak LA, Hannun YA: 1993, Programmed cell death induced by ceramide. Science 259:1769-1771.
81. Palmer DN, Tyynela J, van Mil HC, et al.: 1997, Accumulation of sphingolipid activator proteins (SAPs) A and D in granular osmiophilic deposits in miniature Schnauzer dogs with ceroidlipofuscinosis. J Inner Metab Dis 20:74-84.
82. Pearse AGE: 1961, The plasmal reaction. In: Histochemistry, theoretical and applied, 2nd ed., pp. 347-355. Little, Brown and Company, Boston, MA.
83. Pearse AGE: 1968, Lipids, lipoproteins and proteolipids. In: Histochemistry, theoretical and applied, 2nd ed., vol. 1, pp. 398-446. Little, Brown and Company, Boston, MA.
84. Pearse AGE: 1972, Fluorescene microscopy. In: Histochemistry, theoretical and applied, 3rd ed., vol. 2, pp. 1172-1206. Churchill Livingstone, Edinburgh, Scotland.
85. Pennock CA: 1976, A review and selection of simple laboratory methods used for study of glycosaminoglycan excretion and the diagnosis of the mucopolysaccharidoses. J Clin Pathol 29:111-128.
86. Pierce AM, Lindskog S, Hammarstrom L: 1991, Osteoclasts: structure and function. Electron Microsc Rev 4:1-45.
87. Pitto M, Chigorno V, Renlund M, Tettamanti G: 1996, Impairment of ganglioside metabolism in cultured fibroblasts from Sella patients. Clin Chim Acta 247:143-157.
88. Prasad A, Kaye EM, Alroy J: 1996, Electron microscopic examination of skin biopsy as a cost effective tool in the diagnosis of lysosomal storage diseases. J Child Neurol 11:301-308.
89. Pueschel SM, O'Shea PA, Alroy J, et al.: 1988, Infantile sialic acid storage disease associated with renal disease. Pediatr Neurol 4:207-212.
90. Rapola J: 1993, Neuronal ceroid-lipofuscinoses in childhood. Prospect Pediatr Pathol 17:7-44.
91. M1-gangliosidosis in dogs with β-galactosidase deficiency. J Neuropathol Exp Neurol 41:618-629.
92. Saftig P, Hartmann D, Lullmann-Rauch R, et al.: 1997, Mice deficient in lysosomal acid phosphatase develop lysosomal storage in the kidney and central nervous system. J Biol Chem 272:18628-18635.
93. Sandhoff K, Harzer K, Furst W: 1995, Sphingolipid activator proteins. In: The metabolic and molecular basis of inherited diseases, eds., Scriver CR, Beaudet AL, Sly WS, Valle D, 7th ed., vol. 2, pp. 2427-2441. McGraw Hill, New York, NY.
94. Sands MS, Brikenmeier EH: 1993, A single-base-pair deletion in beta-glucuronidase gene account for the phenotype of murine mucopolysaccharidosis type VII. Proc Natl Acad Sci USA 90:6567-6571.
95. Schiffmann R, Dwyer NK, Lubensky LA, et al.: 1998, Constitutive achlorhydria in mucolipidosis type IV. Proc Natl Acad Sci USA 95:1207-1212.
96. Schmidt B, Selmer T, Ingendoh A, von Figura K: 1995, A novel ammo acid modification in sulfatase that is defective in multiple sulfatase deficiency. Cell 82:271-278.
97. Scriver CR, Beaudet AL, Sly WS, Valle D, eds.: 1995, Lysosomal enzymes. In: The metabolic and molecular basis of inherited diseases, eds., Scriver CR, Beaudet AL, Sly WS, Valle D, 7th ed., vol. 2, pp. 2425-2879, 3763-3797. McGraw Hill, New York, NY.
98. Skelly BJ, Sargan DR, Herrtage ME, Winchester BG: 1996, The molecular defect underlying canine fucosidosis. J Med Genet 33:284-288.
99. Skelly BJ, Sargan DR, Winchester BG, et al.: 1999, Genomic screening for fucosidosis in English Springer Spaniels. J Vet Res 60:726-729.
100. Suzuki K, Suzuki Y, Suzuki K: 1995, Galactosylceramide lipidosis: globoid-cell leukodystrophy (Krabbe disease). In: The metabolic and molecular basis of inherited diseases, eds. Scriver CR, Beaudet AL, Sly WS, Valle D, 7th ed., vol. 2, pp. 2671-2692. McGraw Hill, New York, NY.
101. Svennerholm L, Vanier M-T, Mansson J-E: 1980, Krabbe disease: galactosylsphingosine (psychosine) lipidosis. J Lipid Res 21:53-64.
102. Taniike M, Marcus JR, Nishigaki T, et al.: 1998, Suppressed UDP-galactose: ceramide galactosyltransferase and myelin protein mRNA in Twitcher mouse brain. J Neurosci Res 51: 536-540.
103. Thompson JN, Jones MZ, Dawson G, Huffman PS: 1992, N-acetylglucosamine 6-sulphatase deficiency in Nubian goat: a model of Sanfilippo syndrome type D (mucopolysaccharidosis IIID). J Inher Metab Dis 15:760-768.
104. Tollersrud OK, Berg T, Healy PJ, et al.: 1997, Purification of bovine lysosomal α-mannosidase, characterization of its gene and determination of two mutations that cause α-mannosidosis. Eur J Biochem 246:410-419.
105. Vaananen K: 1996, Osteoclast function. In: Principles of bone biology, eds. Bilezikian JP, Raisz LG, Rodan GA, pp. 103-113. Academic, New York, NY.
106. Victoria T, Rafi MA, Wenger DA: 1996, Cloning of the canine GALC cDNA and identification of the mutation causing Globoid cell leukodystrophy in West Highland White and Cairn Terriers. Genomics 33:457-462.
107. Warren CD, Alroy J, Bugge B, et al.: 1986, Oligosaccharides from placenta: early diagnosis of feline mannosidosis. FEBS Lett 195:247-252.
108. Warren CD, Sadeh S, Daniel PF, et al.: 1993, Induced mannosidosis-excretion of oligosaccharides by locoweed-intoxicated sheep. FEBS Lett 163:99-103.
109. Warren CD, Schmit AS, Jeanloz RW: 1983, Chromatographic separation of Oligosaccharides from mannosidosis urine. Carbohydr Res 116:171-182.
110. Wenger DA, Williams C: 1991, Screening for lysosomal disorders. In: Techniques in diagnostic human biochemical genetics: a laboratory manual. ed. Frist AH, pp. 587-617. Wiley-Liss, New York, NY.